57 related articles for article (PubMed ID: 16890193)
1. Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma.
Hong J; Zhao Y; Huang W
Biochem Biophys Res Commun; 2006 Sep; 348(2):600-5. PubMed ID: 16890193
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
[TBL] [Abstract][Full Text] [Related]
3. esiRNA to eri-1 and adar-1 genes improving high doses of c-myc-directed esiRNA effect on mouse melanoma growth inhibition.
Hong J; Zhao Y; Li Z; Huang W
Biochem Biophys Res Commun; 2007 Sep; 361(2):373-8. PubMed ID: 17658462
[TBL] [Abstract][Full Text] [Related]
4. [Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].
Kabilova TO; Vladimirova AV; Repkova MN; Ven'iaminova AG; Chernolovskaia EL; Vlasov VV
Mol Biol (Mosk); 2006; 40(6):1037-46. PubMed ID: 17209432
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
[TBL] [Abstract][Full Text] [Related]
6. Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma.
Klosek SK; Nakashiro K; Hara S; Goda H; Hamakawa H
Oncol Rep; 2008 Oct; 20(4):873-8. PubMed ID: 18813829
[TBL] [Abstract][Full Text] [Related]
7. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
8. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
[TBL] [Abstract][Full Text] [Related]
9. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
10. Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35).
Sarkar D; Park ES; Fisher PB
Cell Death Differ; 2006 Sep; 13(9):1541-53. PubMed ID: 16410805
[TBL] [Abstract][Full Text] [Related]
11. Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach.
Jiang K; Krous LC; Knowlton N; Chen Y; Frank MB; Cadwell C; Centola M; Jarvis JN
Placenta; 2009 Sep; 30(9):806-15. PubMed ID: 19616846
[TBL] [Abstract][Full Text] [Related]
12. Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer.
Pries R; Hogrefe L; Xie L; Frenzel H; Brocks C; Ditz C; Wollenberg B
Int J Mol Med; 2008 Feb; 21(2):209-15. PubMed ID: 18204787
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
15. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of STAT3, VEGF and C-myc in seminoma and their significance].
Li W; Li JJ; Li GL
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):26-30. PubMed ID: 19288744
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf.
Nakai N; Kishida T; Shin-Ya M; Imanishi J; Ueda Y; Kishimoto S; Mazda O
Gene Ther; 2007 Feb; 14(4):357-65. PubMed ID: 17024102
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
20. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
